A 'vaccine-like' version of Wegovy is on the drawing board at Novo Nordisk

By STAT News
| February 29, 2024

Novo Nordisk, the pharma company behind Wegovy, faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...